Cambrex Tech Stack

Contract drug manufacturing and development across the pharmaceutical lifecycle

Pharmaceutical Manufacturing East Rutherford, New Jersey 1,001–5,000 employees Privately Held

Cambrex operates a CDMO business spanning drug substance development, manufacturing, and analytical services across North America and Europe. The tech stack is heavily weighted toward analytical instruments (HPLC, LC-MS, GC/MS, UHPLC, FT-IR) and manufacturing control systems (SAP, Ignition, Siemens S7), with active adoption of LIMS—a signal of effort to standardize lab data capture across dispersed facilities. Manufacturing and research roles dominate hiring, aligned with a project roadmap focused on continuous-flow process design and reactor development.

Tech Stack 14 technologies

Core StackAutoCAD SAP HPLC GCP GC/MS LC-MS UHPLC LIMS FT-IR Siemens S7 Ignition Plant 3D Ariba Concur

AdoptingLIMS

What Cambrex Is Building

◆Challenges

Ensuring gmp compliance
Developing alternate chemistry
Optimizing chemical routes
Optimizing production facilities
Meeting customer demands
Site improvement programs
Grow early-stage cmc business
Process improvements for yield
Timely revenue recognition
Financial monitoring invoicing

▲Active Projects

Continuous flow synthetic route design
Reactor system development
Operational excellence improvement program
Technology transfer
Development of alternate chemistry toward key synthetic intermediates and apis
Optimization of existing chemical routes
Delivery of intermediates, apis and high value specialty chemicals
Plant improvement initiatives
Continuous flow process development
Development of reactor systems incorporating cutting-edge flow technology

Hiring Activity

Steady90 roles · 40 in 30d

Department

Manufacturing

Research

Engineering

Ops

Finance

Logistics

Product

Quality

Seniority

Mid

Senior

Junior

Principal

Intern

Manager

Director

Lead

Notable leadership hires: Production Head

Company intelligence

Find more companies like Cambrex by tech stack, pain points and active projects

Get started free

About Cambrex

Cambrex is a contract development and manufacturing organization (CDMO) serving pharmaceutical clients with drug substance services, drug product services, and analytical capabilities. The company operates from North America and Europe with a 2,000-person workforce. Service portfolio includes continuous flow synthesis, controlled substance manufacturing, liquid-phase peptide synthesis, solid-state science, and highly potent active pharmaceutical ingredients (APIs). The business spans the full drug lifecycle—from early development through commercial scale—and includes IND-enabling analytical work. Current operational focus is on continuous-flow process optimization, reactor system development, alternate chemistry routes, and facility improvement initiatives.

HeadquartersEast Rutherford, New Jersey

Company Size1,001–5,000 employees

Hiring MarketsUnited States, Italy, United Kingdom, Ireland, Sweden

Frequently Asked Questions

What is Cambrex's tech stack?

Cambrex uses HPLC, LC-MS, GC/MS, UHPLC, FT-IR for analytical work; SAP and Concur for enterprise operations; Ignition and Siemens S7 for manufacturing control; and LIMS for laboratory data management. They are actively adopting LIMS across facilities.

What is Cambrex working on?

Active projects include continuous-flow synthetic route design, reactor system development incorporating flow technology, operational excellence improvements, technology transfer, alternate chemistry development for APIs and intermediates, and plant improvement initiatives.